WASHINGTON, Aug. 27 -- The International Society for CNS Clinical Trials and Methodology has issued a public comment to the U.S. Department of Health and Human Services. The comment was written on Aug. 22, 2023, and posted on Aug. 23, 2023. The comment was on Docket No. FDA-2023-D-1987. * * * The ISCTM thanks the FDA for the opportunity to comment on the draft guidance Psychedelic Drugs: Considerations for Clinical Investigations, Guidance for Industry. The ISCTM formed a working group to rev  more